Setmelanotide for controlling weight and hunger in Bardet-Biedl syndrome

Lancet Diabetes Endocrinol. 2022 Dec;10(12):829-830. doi: 10.1016/S2213-8587(22)00309-6. Epub 2022 Nov 7.

Author

Maithe Tauber¹

Affiliation

¹ Centre de Référence Maladies Rares PRADORT, Hôpital des Enfants, CHU Toulouse, Université Toulouse III, Toulouse, France; Infinity, INSERM UMR 1291-CNRS UMR 5051, Université Toulouse III, Toulouse, France. Electronic address: tauber.mt@chu-toulouse.fr.

PMID: 36356611
DOI: 10.1016/S2213-8587(22)00309-6

No abstract available

Publication types

Comment

MeSH terms

Bardet-Biedl Syndrome*
Humans
Hunger
alpha-MSH

Substances

setmelanotide
alpha-MSH